Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders

Dario Finazzi, Emanuela Castiglioni, Stefano Goldwurm, Gianni Pezzoli, Gianluca Forni, Domenico Girelli, Federica MacCarinelli, Maura Poli, Maurizio Ferrari, Laura Cremonesi, Paolo Arosio

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The capacity to act as an electron donor and acceptor makes iron an essential cofactor of many vital processes. Its balance in the body has to be tightly regulated since its excess can be harmful by favouring oxidative damage, while its deficiency can impair fundamental activities like erythropoiesis. In the brain, an accumulation of iron or an increase in its availability has been associated with the development and/or progression of different degenerative processes, including Parkinson's disease, while iron paucity seems to be associated with cognitive deficits, motor dysfunction, and restless legs syndrome. In the search of DNA sequence variations affecting the individual predisposition to develop movement disorders, we scanned by DHPLC the exons and intronic boundary regions of ceruloplasmin, iron regulatory protein 2, hemopexin, hepcidin and hemojuvelin genes in cohorts of subjects affected by Parkinson's disease and idiopathic neurodegeneration with brain iron accumulation (NBIA). Both novel and known sequence variations were identified in most of the genes, but none of them seemed to be significantly associated to the movement diseases of interest.

Original languageEnglish
Article number827693
JournalParkinson's Disease
DOIs
Publication statusPublished - 2011

Fingerprint

Movement Disorders
Parkinson Disease
Nucleotides
Iron
Iron Regulatory Protein 2
Hemopexin
Hepcidins
Genes
Restless Legs Syndrome
Ceruloplasmin
Erythropoiesis
Exons
Tissue Donors
Electrons
Brain

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders. / Finazzi, Dario; Castiglioni, Emanuela; Goldwurm, Stefano; Pezzoli, Gianni; Forni, Gianluca; Girelli, Domenico; MacCarinelli, Federica; Poli, Maura; Ferrari, Maurizio; Cremonesi, Laura; Arosio, Paolo.

In: Parkinson's Disease, 2011.

Research output: Contribution to journalArticle

Finazzi, D, Castiglioni, E, Goldwurm, S, Pezzoli, G, Forni, G, Girelli, D, MacCarinelli, F, Poli, M, Ferrari, M, Cremonesi, L & Arosio, P 2011, 'Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders', Parkinson's Disease. https://doi.org/10.4061/2011/827693
Finazzi, Dario ; Castiglioni, Emanuela ; Goldwurm, Stefano ; Pezzoli, Gianni ; Forni, Gianluca ; Girelli, Domenico ; MacCarinelli, Federica ; Poli, Maura ; Ferrari, Maurizio ; Cremonesi, Laura ; Arosio, Paolo. / Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders. In: Parkinson's Disease. 2011.
@article{b61f643548bb48b59277ef1761d21115,
title = "Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders",
abstract = "The capacity to act as an electron donor and acceptor makes iron an essential cofactor of many vital processes. Its balance in the body has to be tightly regulated since its excess can be harmful by favouring oxidative damage, while its deficiency can impair fundamental activities like erythropoiesis. In the brain, an accumulation of iron or an increase in its availability has been associated with the development and/or progression of different degenerative processes, including Parkinson's disease, while iron paucity seems to be associated with cognitive deficits, motor dysfunction, and restless legs syndrome. In the search of DNA sequence variations affecting the individual predisposition to develop movement disorders, we scanned by DHPLC the exons and intronic boundary regions of ceruloplasmin, iron regulatory protein 2, hemopexin, hepcidin and hemojuvelin genes in cohorts of subjects affected by Parkinson's disease and idiopathic neurodegeneration with brain iron accumulation (NBIA). Both novel and known sequence variations were identified in most of the genes, but none of them seemed to be significantly associated to the movement diseases of interest.",
author = "Dario Finazzi and Emanuela Castiglioni and Stefano Goldwurm and Gianni Pezzoli and Gianluca Forni and Domenico Girelli and Federica MacCarinelli and Maura Poli and Maurizio Ferrari and Laura Cremonesi and Paolo Arosio",
year = "2011",
doi = "10.4061/2011/827693",
language = "English",
journal = "Parkinson's Disease",
issn = "2090-8083",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders

AU - Finazzi, Dario

AU - Castiglioni, Emanuela

AU - Goldwurm, Stefano

AU - Pezzoli, Gianni

AU - Forni, Gianluca

AU - Girelli, Domenico

AU - MacCarinelli, Federica

AU - Poli, Maura

AU - Ferrari, Maurizio

AU - Cremonesi, Laura

AU - Arosio, Paolo

PY - 2011

Y1 - 2011

N2 - The capacity to act as an electron donor and acceptor makes iron an essential cofactor of many vital processes. Its balance in the body has to be tightly regulated since its excess can be harmful by favouring oxidative damage, while its deficiency can impair fundamental activities like erythropoiesis. In the brain, an accumulation of iron or an increase in its availability has been associated with the development and/or progression of different degenerative processes, including Parkinson's disease, while iron paucity seems to be associated with cognitive deficits, motor dysfunction, and restless legs syndrome. In the search of DNA sequence variations affecting the individual predisposition to develop movement disorders, we scanned by DHPLC the exons and intronic boundary regions of ceruloplasmin, iron regulatory protein 2, hemopexin, hepcidin and hemojuvelin genes in cohorts of subjects affected by Parkinson's disease and idiopathic neurodegeneration with brain iron accumulation (NBIA). Both novel and known sequence variations were identified in most of the genes, but none of them seemed to be significantly associated to the movement diseases of interest.

AB - The capacity to act as an electron donor and acceptor makes iron an essential cofactor of many vital processes. Its balance in the body has to be tightly regulated since its excess can be harmful by favouring oxidative damage, while its deficiency can impair fundamental activities like erythropoiesis. In the brain, an accumulation of iron or an increase in its availability has been associated with the development and/or progression of different degenerative processes, including Parkinson's disease, while iron paucity seems to be associated with cognitive deficits, motor dysfunction, and restless legs syndrome. In the search of DNA sequence variations affecting the individual predisposition to develop movement disorders, we scanned by DHPLC the exons and intronic boundary regions of ceruloplasmin, iron regulatory protein 2, hemopexin, hepcidin and hemojuvelin genes in cohorts of subjects affected by Parkinson's disease and idiopathic neurodegeneration with brain iron accumulation (NBIA). Both novel and known sequence variations were identified in most of the genes, but none of them seemed to be significantly associated to the movement diseases of interest.

UR - http://www.scopus.com/inward/record.url?scp=78349265774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349265774&partnerID=8YFLogxK

U2 - 10.4061/2011/827693

DO - 10.4061/2011/827693

M3 - Article

JO - Parkinson's Disease

JF - Parkinson's Disease

SN - 2090-8083

M1 - 827693

ER -